Process View
Any process that activates or increases the frequency, rate or extent of the JAK-STAT signaling pathway activity.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "positive regulation of jak stat cascade"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 1.000 | Human | |
EGFR | epidermal growth factor receptor | 1.000 | Human | |
PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.997 | ||
TRAF1 | TNF receptor-associated factor 1 | 0.991 | ||
SOCS3 | suppressor of cytokine signaling 3 | 0.982 | ||
IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) | 0.977 | ||
IL6 | interleukin 6 (interferon, beta 2) | 0.969 | ||
BCAR1 | breast cancer anti-estrogen resistance 1 | 0.966 | ||
IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.966 | ||
CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.963 | ||
TRADD | TNFRSF1A-associated via death domain | 0.954 | ||
FADD | Fas (TNFRSF6)-associated via death domain | 0.935 | ||
TRAF2 | TNF receptor-associated factor 2 | 0.925 | ||
JAK2 | Janus kinase 2 | 0.906 | Mouse | |
PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.885 | Human | |
RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.865 | ||
ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.843 | Human | |
PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.818 | ||
CCR5 | chemokine (C-C motif) receptor 5 | 0.803 | ||
CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.790 | ||
FGF1 | fibroblast growth factor 1 (acidic) | 0.787 | ||
TNF | tumor necrosis factor | 0.777 | ||
TNFRSF10A | tumor necrosis factor receptor superfamily, member 10a | 0.751 | Human | |
TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b | 0.731 | Human | |
TRAF5 | TNF receptor-associated factor 5 | 0.702 | ||
IL8 | interleukin 8 | 0.674 | ||
CFLAR | CASP8 and FADD-like apoptosis regulator | 0.671 | ||
CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.656 | ||
CCL4 | chemokine (C-C motif) ligand 4 | 0.652 | Human | |
SYK | spleen tyrosine kinase | 0.607 | ||
CCL2 | chemokine (C-C motif) ligand 2 | 0.570 | Human | |
CAV1 | caveolin 1, caveolae protein, 22kDa | 0.558 | ||
PTK2 | PTK2 protein tyrosine kinase 2 | 0.541 | Human | |
FYN | FYN oncogene related to SRC, FGR, YES | 0.534 | ||
SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.520 | ||
LAT | linker for activation of T cells | 0.517 | ||
CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.505 | ||
CSH1 | chorionic somatomammotropin hormone 1 (placental lactogen) | 0.500 | Human | |
CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.494 | ||
ICAM1 | intercellular adhesion molecule 1 | 0.494 | ||
GH1 | growth hormone 1 | 0.494 | ||
JAG1 | jagged 1 | 0.489 | ||
PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 0.478 | ||
TNFSF10 | tumor necrosis factor (ligand) superfamily, member 10 | 0.439 | ||
IL1B | interleukin 1, beta | 0.433 | ||
CCL5 | chemokine (C-C motif) ligand 5 | 0.413 | ||
TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.397 | ||
PTPN11 | protein tyrosine phosphatase, non-receptor type 11 | 0.397 | ||
BIRC3 | baculoviral IAP repeat containing 3 | 0.393 | ||
TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 0.379 | Human | |
LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 0.375 | ||
EPOR | erythropoietin receptor | 0.351 | ||
VEGFA | vascular endothelial growth factor A | 0.344 | ||
SOS1 | son of sevenless homolog 1 (Drosophila) | 0.342 | ||
RBPJ | recombination signal binding protein for immunoglobulin kappa J region | 0.328 | ||
CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.317 | ||
FGFR1 | fibroblast growth factor receptor 1 | 0.311 | Human | |
CCL7 | chemokine (C-C motif) ligand 7 | 0.296 | Human | |
STAT4 | signal transducer and activator of transcription 4 | 0.286 | ||
CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.261 | Rat | |
CSHL1 | chorionic somatomammotropin hormone-like 1 | 0.250 | Human | |
CSF2RA | colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) | 0.247 | ||
STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.242 | ||
CXCL6 | chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) | 0.225 | Rat | |
PTPRB | protein tyrosine phosphatase, receptor type, B | 0.221 | ||
IL23A | interleukin 23, alpha subunit p19 | 0.219 | ||
NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.215 | ||
DDIT3 | DNA-damage-inducible transcript 3 | 0.215 | ||
IL6R | interleukin 6 receptor | 0.207 | ||
JAK1 | Janus kinase 1 | 0.194 | ||
CCR7 | chemokine (C-C motif) receptor 7 | 0.191 | ||
GRB2 | growth factor receptor-bound protein 2 | 0.189 | ||
CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.179 | ||
CSF2RB | colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) | 0.176 | ||
CCL20 | chemokine (C-C motif) ligand 20 | 0.175 | Human | |
SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.173 | ||
GHR | growth hormone receptor | 0.172 | Rat | |
CCL8 | chemokine (C-C motif) ligand 8 | 0.168 | Human | |
FGR | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog | 0.165 | ||
IGF1R | insulin-like growth factor 1 receptor | 0.159 | ||
GAB1 | GRB2-associated binding protein 1 | 0.150 | ||
NOTCH3 | notch 3 | 0.150 | ||
INSR | insulin receptor | 0.149 | ||
TGIF1 | TGFB-induced factor homeobox 1 | 0.140 | ||
PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.136 | ||
TFF1 | trefoil factor 1 | 0.130 | ||
ARRB1 | arrestin, beta 1 | 0.129 | ||
CCL11 | chemokine (C-C motif) ligand 11 | 0.128 | Human | |
FASLG | Fas ligand (TNF superfamily, member 6) | 0.126 | ||
LIF | leukemia inhibitory factor (cholinergic differentiation factor) | 0.125 | ||
CSH2 | chorionic somatomammotropin hormone 2 | 0.125 | Human | |
IFNG | interferon, gamma | 0.123 | ||
GAB2 | GRB2-associated binding protein 2 | 0.123 | ||
LCP2 | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) | 0.120 | ||
CCL22 | chemokine (C-C motif) ligand 22 | 0.119 | ||
IL2RB | interleukin 2 receptor, beta | 0.117 | ||
CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.112 | ||
APP | amyloid beta (A4) precursor protein | 0.111 | ||
BBS10 | Bardet-Biedl syndrome 10 | 0.110 | ||
PROX1 | prospero homeobox 1 | 0.109 | ||
TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.106 | ||
SH2D4A | SH2 domain containing 4A | 0.102 | ||
TRAF3 | TNF receptor-associated factor 3 | 0.102 | ||
OSMR | oncostatin M receptor | 0.102 | Human | |
FGFR2 | fibroblast growth factor receptor 2 | 0.098 | Human | |
PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 0.094 | ||
IL7R | interleukin 7 receptor | 0.094 | ||
CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.093 | ||
VCAM1 | vascular cell adhesion molecule 1 | 0.093 | ||
PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.089 | ||
CCL19 | chemokine (C-C motif) ligand 19 | 0.088 | Human | |
SELE | selectin E | 0.086 | ||
GH2 | growth hormone 2 | 0.081 | Human | |
CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.081 | ||
WAS | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 0.079 | ||
IL12A | interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) | 0.078 | ||
CSF1 | colony stimulating factor 1 (macrophage) | 0.077 | ||
NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 | 0.076 | ||
CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.076 | ||
CSF3 | colony stimulating factor 3 (granulocyte) | 0.074 | ||
FRS2 | fibroblast growth factor receptor substrate 2 | 0.069 | ||
MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 0.067 | ||
CCL3 | chemokine (C-C motif) ligand 3 | 0.065 | Human | |
PECAM1 | platelet/endothelial cell adhesion molecule | 0.064 | ||
IL4R | interleukin 4 receptor | 0.064 | ||
KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 0.063 | ||
KITLG | KIT ligand | 0.062 | ||
PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.060 | Human | |
MOBKL1B | MOB1, Mps One Binder kinase activator-like 1B (yeast) | 0.060 | ||
CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.060 | ||
SPEN | spen homolog, transcriptional regulator (Drosophila) | 0.059 | ||
CCR1 | chemokine (C-C motif) receptor 1 | 0.059 | ||
IDE | insulin-degrading enzyme | 0.058 | ||
CD33 | CD33 molecule | 0.055 | ||
RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.053 | ||
ANKS1B | ankyrin repeat and sterile alpha motif domain containing 1B | 0.052 | ||
STAT5A | signal transducer and activator of transcription 5A | 0.052 | ||
NKG7 | natural killer cell group 7 sequence | 0.052 | ||
CH25H | cholesterol 25-hydroxylase | 0.052 | ||
MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.051 | ||
CTBP1 | C-terminal binding protein 1 | 0.051 | Fly | |
CXCR6 | chemokine (C-X-C motif) receptor 6 | 0.050 | ||
FGF7 | fibroblast growth factor 7 | 0.046 | ||
IL9 | interleukin 9 | 0.046 | ||
VAV1 | vav 1 guanine nucleotide exchange factor | 0.046 | ||
PLCG1 | phospholipase C, gamma 1 | 0.046 | ||
PGF | placental growth factor | 0.045 | ||
IL1A | interleukin 1, alpha | 0.045 | ||
PTK2B | PTK2B protein tyrosine kinase 2 beta | 0.045 | ||
SH3BP2 | SH3-domain binding protein 2 | 0.044 | ||
OSM | oncostatin M | 0.044 | ||
CCL13 | chemokine (C-C motif) ligand 13 | 0.043 | Human | |
PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.043 | ||
FGF10 | fibroblast growth factor 10 | 0.043 | ||
WIPF1 | WAS/WASL interacting protein family, member 1 | 0.043 | ||
FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.043 | Human | |
NRP1 | neuropilin 1 | 0.042 | ||
SLA | Src-like-adaptor | 0.041 | ||
PTPN12 | protein tyrosine phosphatase, non-receptor type 12 | 0.040 | ||
BAZ2B | bromodomain adjacent to zinc finger domain, 2B | 0.040 | ||
TBP | TATA box binding protein | 0.040 | ||
ITGB2 | integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) | 0.039 | ||
IRS1 | insulin receptor substrate 1 | 0.039 | ||
BCL2A1 | BCL2-related protein A1 | 0.038 | ||
TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.037 | ||
JAK3 | Janus kinase 3 | 0.037 | ||
MATK | megakaryocyte-associated tyrosine kinase | 0.037 | ||
RAPGEF1 | Rap guanine nucleotide exchange factor (GEF) 1 | 0.036 | ||
ID1 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | 0.036 | ||
PDGFA | platelet-derived growth factor alpha polypeptide | 0.035 | ||
IKBKE | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon | 0.035 | ||
DOCK8 | dedicator of cytokinesis 8 | 0.035 | ||
GNLY | granulysin | 0.035 | ||
SOCS1 | suppressor of cytokine signaling 1 | 0.035 | Mouse | |
GRB7 | growth factor receptor-bound protein 7 | 0.035 | ||
SOCS2 | suppressor of cytokine signaling 2 | 0.033 | ||
MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.032 | ||
IL2RG | interleukin 2 receptor, gamma | 0.032 | ||
CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.032 | Human | |
MAP4K1 | mitogen-activated protein kinase kinase kinase kinase 1 | 0.031 | ||
FGF2 | fibroblast growth factor 2 (basic) | 0.031 | ||
SREBF2 | sterol regulatory element binding transcription factor 2 | 0.031 | ||
RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 0.030 | ||
IL4 | interleukin 4 | 0.030 | Mouse | |
HLA-DOA | major histocompatibility complex, class II, DO alpha | 0.030 | ||
IL11 | interleukin 11 | 0.030 | ||
SRCIN1 | SRC kinase signaling inhibitor 1 | 0.029 | ||
ICA1 | islet cell autoantigen 1, 69kDa | 0.029 | ||
CXCR3 | chemokine (C-X-C motif) receptor 3 | 0.029 | ||
UBD | ubiquitin D | 0.029 | ||
FAS | Fas (TNF receptor superfamily, member 6) | 0.028 | Human | |
GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | 0.028 | ||
DPP4 | dipeptidyl-peptidase 4 | 0.028 | ||
MSC | musculin | 0.028 | ||
ADAMDEC1 | ADAM-like, decysin 1 | 0.028 | ||
NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.028 | ||
IFNGR1 | interferon gamma receptor 1 | 0.028 | ||
INHBA | inhibin, beta A | 0.028 | ||
IL21R | interleukin 21 receptor | 0.028 | ||
PIK3R2 | phosphoinositide-3-kinase, regulatory subunit 2 (beta) | 0.027 | ||
TIFA | TRAF-interacting protein with forkhead-associated domain | 0.027 | ||
PTEN | phosphatase and tensin homolog | 0.027 | ||
RUNX3 | runt-related transcription factor 3 | 0.027 | ||
KCNA1 | potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia) | 0.026 | ||
PSTPIP1 | proline-serine-threonine phosphatase interacting protein 1 | 0.026 | ||
GPR171 | G protein-coupled receptor 171 | 0.026 | ||
CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.026 | ||
IGF2R | insulin-like growth factor 2 receptor | 0.025 | ||
KRT8 | keratin 8 | 0.025 | ||
MMP14 | matrix metallopeptidase 14 (membrane-inserted) | 0.025 | ||
DDR2 | discoidin domain receptor tyrosine kinase 2 | 0.025 | ||
IL12RB1 | interleukin 12 receptor, beta 1 | 0.025 | ||
TNFSF14 | tumor necrosis factor (ligand) superfamily, member 14 | 0.025 | ||
CDC42 | cell division cycle 42 (GTP binding protein, 25kDa) | 0.025 | ||
TNFRSF13B | tumor necrosis factor receptor superfamily, member 13B | 0.024 | ||
IRF4 | interferon regulatory factor 4 | 0.024 | ||
LIFR | leukemia inhibitory factor receptor alpha | 0.024 | Human | |
SLAMF1 | signaling lymphocytic activation molecule family member 1 | 0.024 | ||
IL10 | interleukin 10 | 0.024 | ||
ASAP1 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 | 0.023 | ||
CD27 | CD27 molecule | 0.023 | ||
STC1 | stanniocalcin 1 | 0.023 | ||
SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.023 | ||
ADAM15 | ADAM metallopeptidase domain 15 | 0.022 | ||
CCR3 | chemokine (C-C motif) receptor 3 | 0.022 | ||
PRF1 | perforin 1 (pore forming protein) | 0.022 | ||
NNMT | nicotinamide N-methyltransferase | 0.022 | ||
STAT1 | signal transducer and activator of transcription 1, 91kDa | 0.022 | ||
CTSW | cathepsin W | 0.022 | ||
LTA | lymphotoxin alpha (TNF superfamily, member 1) | 0.022 | ||
KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.022 | Human | |
KLRD1 | killer cell lectin-like receptor subfamily D, member 1 | 0.022 | ||
CD83 | CD83 molecule | 0.022 | ||
MAML1 | mastermind-like 1 (Drosophila) | 0.021 | ||
LAIR1 | leukocyte-associated immunoglobulin-like receptor 1 | 0.021 | ||
STAB1 | stabilin 1 | 0.021 | ||
DNAJC1 | DnaJ (Hsp40) homolog, subfamily C, member 1 | 0.021 | ||
PLEK | pleckstrin | 0.021 | ||
CTBP2 | C-terminal binding protein 2 | 0.021 | Fly | |
DLG4 | discs, large homolog 4 (Drosophila) | 0.021 | ||
TFPI2 | tissue factor pathway inhibitor 2 | 0.021 | ||
TAF1 | TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa | 0.021 | ||
TFPI | tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) | 0.021 | ||
SPRR2A | small proline-rich protein 2A | 0.021 | ||
IL3 | interleukin 3 (colony-stimulating factor, multiple) | 0.021 | ||
CCL1 | chemokine (C-C motif) ligand 1 | 0.021 | ||
EXT1 | exostosin 1 | 0.020 | ||
PDGFC | platelet derived growth factor C | 0.020 | ||
DARC | Duffy blood group, chemokine receptor | 0.020 | ||
GFPT2 | glutamine-fructose-6-phosphate transaminase 2 | 0.020 | ||
PRLR | prolactin receptor | 0.020 | ||
PTPN3 | protein tyrosine phosphatase, non-receptor type 3 | 0.020 | ||
MMP10 | matrix metallopeptidase 10 (stromelysin 2) | 0.020 | ||
CD3E | CD3e molecule, epsilon (CD3-TCR complex) | 0.019 | ||
IL5 | interleukin 5 (colony-stimulating factor, eosinophil) | 0.019 | ||
TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.019 | ||
VAV3 | vav 3 guanine nucleotide exchange factor | 0.019 | ||
IL32 | interleukin 32 | 0.019 | ||
MMP7 | matrix metallopeptidase 7 (matrilysin, uterine) | 0.018 | ||
IL18RAP | interleukin 18 receptor accessory protein | 0.018 | ||
CCR4 | chemokine (C-C motif) receptor 4 | 0.018 | ||
IL16 | interleukin 16 (lymphocyte chemoattractant factor) | 0.018 | ||
MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.018 | ||
CD7 | CD7 molecule | 0.018 | ||
LCORL | ligand dependent nuclear receptor corepressor-like | 0.018 | ||
MAGEA11 | melanoma antigen family A, 11 | 0.018 | ||
RGS1 | regulator of G-protein signaling 1 | 0.018 | ||
RARRES1 | retinoic acid receptor responder (tazarotene induced) 1 | 0.018 | ||
C5AR1 | complement component 5a receptor 1 | 0.017 | ||
SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | 0.017 | ||
ARID1A | AT rich interactive domain 1A (SWI-like) | 0.017 | ||
BATF | basic leucine zipper transcription factor, ATF-like | 0.017 | ||
IL13 | interleukin 13 | 0.017 | ||
LY6G6F | lymphocyte antigen 6 complex, locus G6F | 0.017 | ||
PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 0.017 | ||
CSK | c-src tyrosine kinase | 0.017 | ||
MAP3K14 | mitogen-activated protein kinase kinase kinase 14 | 0.017 | ||
KIR2DL1 | killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1 | 0.017 | ||
TNC | tenascin C | 0.017 | ||
CHI3L2 | chitinase 3-like 2 | 0.017 | ||
MMP3 | matrix metallopeptidase 3 (stromelysin 1, progelatinase) | 0.016 | ||
FGFR3 | fibroblast growth factor receptor 3 | 0.016 | ||
NR0B2 | nuclear receptor subfamily 0, group B, member 2 | 0.016 | ||
XCL2 | chemokine (C motif) ligand 2 | 0.016 | ||
HIC1 | hypermethylated in cancer 1 | 0.016 | ||
IDO1 | indoleamine 2,3-dioxygenase 1 | 0.016 | ||
XIAP | X-linked inhibitor of apoptosis | 0.016 | ||
SLAMF7 | SLAM family member 7 | 0.016 | ||
ESRRG | estrogen-related receptor gamma | 0.016 | ||
CD163 | CD163 molecule | 0.016 | ||
SASH3 | SAM and SH3 domain containing 3 | 0.016 | ||
CSF2 | colony stimulating factor 2 (granulocyte-macrophage) | 0.016 | ||
AKAP2 | A kinase (PRKA) anchor protein 2 | 0.016 | ||
AXL | AXL receptor tyrosine kinase | 0.016 | ||
DLG3 | discs, large homolog 3 (Drosophila) | 0.016 | ||
LAMP3 | lysosomal-associated membrane protein 3 | 0.016 | ||
TRO | trophinin | 0.016 | ||
HCK | hemopoietic cell kinase | 0.015 | ||
IL2RA | interleukin 2 receptor, alpha | 0.015 | ||
ITK | IL2-inducible T-cell kinase | 0.015 | ||
GRIN2C | glutamate receptor, ionotropic, N-methyl D-aspartate 2C | 0.015 | ||
AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.015 | ||
HK3 | hexokinase 3 (white cell) | 0.015 | ||
TGOLN2 | trans-golgi network protein 2 | 0.015 | ||
IFNB1 | interferon, beta 1, fibroblast | 0.015 | Human | |
MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.015 | ||
MTDH | metadherin | 0.015 | ||
ADH1B | alcohol dehydrogenase 1B (class I), beta polypeptide | 0.015 | ||
DLG2 | discs, large homolog 2 (Drosophila) | 0.015 | ||
PTPRA | protein tyrosine phosphatase, receptor type, A | 0.015 | ||
LDLR | low density lipoprotein receptor | 0.015 | ||
PTPN2 | protein tyrosine phosphatase, non-receptor type 2 | 0.015 | ||
MPZL1 | myelin protein zero-like 1 | 0.015 | ||
LAG3 | lymphocyte-activation gene 3 | 0.015 | ||
RASGEF1C | RasGEF domain family, member 1C | 0.015 | ||
FHL1 | four and a half LIM domains 1 | 0.015 | ||
ITGB1BP1 | integrin beta 1 binding protein 1 | 0.015 | ||
IRF8 | interferon regulatory factor 8 | 0.015 | ||
TNFSF9 | tumor necrosis factor (ligand) superfamily, member 9 | 0.015 | ||
FOSL1 | FOS-like antigen 1 | 0.014 | ||
SAA2 | serum amyloid A2 | 0.014 | ||
CD6 | CD6 molecule | 0.014 | ||
CCL17 | chemokine (C-C motif) ligand 17 | 0.014 | ||
SOX13 | SRY (sex determining region Y)-box 13 | 0.014 | ||
TLR3 | toll-like receptor 3 | 0.014 | ||
EBI3 | Epstein-Barr virus induced 3 | 0.014 | Human | |
SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.014 | ||
PI3 | peptidase inhibitor 3, skin-derived | 0.014 | ||
CYTH4 | cytohesin 4 | 0.014 | ||
NOV | nephroblastoma overexpressed gene | 0.014 | ||
IL1R1 | interleukin 1 receptor, type I | 0.014 | ||
FCER1G | Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide | 0.014 | ||
ADRB2 | adrenergic, beta-2-, receptor, surface | 0.014 | ||
SNAI1 | snail homolog 1 (Drosophila) | 0.014 | ||
CD28 | CD28 molecule | 0.014 | ||
CTLA4 | cytotoxic T-lymphocyte-associated protein 4 | 0.014 | ||
EDNRB | endothelin receptor type B | 0.014 | ||
PRKCQ | protein kinase C, theta | 0.014 | ||
CD2 | CD2 molecule | 0.014 | ||
IL2 | interleukin 2 | 0.014 | ||
CD22 | CD22 molecule | 0.013 | ||
ABL2 | v-abl Abelson murine leukemia viral oncogene homolog 2 | 0.013 | ||
UBASH3B | ubiquitin associated and SH3 domain containing B | 0.013 | ||
CASP9 | caspase 9, apoptosis-related cysteine peptidase | 0.013 | ||
CASP7 | caspase 7, apoptosis-related cysteine peptidase | 0.013 | ||
MTA3 | metastasis associated 1 family, member 3 | 0.013 | ||
FCGR3B | Fc fragment of IgG, low affinity IIIb, receptor (CD16b) | 0.013 | ||
IL18R1 | interleukin 18 receptor 1 | 0.013 | ||
PROCR | protein C receptor, endothelial | 0.013 | ||
ESR1 | estrogen receptor 1 | 0.013 | ||
CMIP | c-Maf-inducing protein | 0.013 | ||
SERPINB2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 | 0.013 | ||
CCL3L3 | chemokine (C-C motif) ligand 3-like 3 | 0.013 | ||
HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 | 0.013 | ||
ATF4 | activating transcription factor 4 (tax-responsive enhancer element B67) | 0.013 | ||
TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.013 | ||
PLAUR | plasminogen activator, urokinase receptor | 0.013 | ||
IL19 | interleukin 19 | 0.013 | ||
IL4I1 | interleukin 4 induced 1 | 0.013 | ||
CAV2 | caveolin 2 | 0.013 | ||
GARS | glycyl-tRNA synthetase | 0.013 | ||
KLRB1 | killer cell lectin-like receptor subfamily B, member 1 | 0.013 | ||
NRIP1 | nuclear receptor interacting protein 1 | 0.013 | ||
TRAF3IP2 | TRAF3 interacting protein 2 | 0.013 | ||
EDN1 | endothelin 1 | 0.013 | ||
MED28 | mediator complex subunit 28 | 0.013 | ||
PLA2G2A | phospholipase A2, group IIA (platelets, synovial fluid) | 0.013 | ||
PAEP | progestagen-associated endometrial protein | 0.013 | ||
FCGR2B | Fc fragment of IgG, low affinity IIb, receptor (CD32) | 0.013 | ||
CHI3L1 | chitinase 3-like 1 (cartilage glycoprotein-39) | 0.012 | ||
SIGLEC10 | sialic acid binding Ig-like lectin 10 | 0.012 | ||
IL3RA | interleukin 3 receptor, alpha (low affinity) | 0.012 | ||
NFKBIZ | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | 0.012 | ||
NCKAP1L | NCK-associated protein 1-like | 0.012 | ||
CLTC | clathrin, heavy chain (Hc) | 0.012 | ||
PTX3 | pentraxin 3, long | 0.012 | ||
CCL23 | chemokine (C-C motif) ligand 23 | 0.012 | Human | |
CSNK1E | casein kinase 1, epsilon | 0.012 | ||
CD40LG | CD40 ligand | 0.012 | ||
IL24 | interleukin 24 | 0.012 | Rat | |
SOD2 | superoxide dismutase 2, mitochondrial | 0.012 | ||
INPPL1 | inositol polyphosphate phosphatase-like 1 | 0.012 | ||
CSF1R | colony stimulating factor 1 receptor | 0.012 | Human Mouse | |
IL12RB2 | interleukin 12 receptor, beta 2 | 0.012 | Human | |
TRIB3 | tribbles homolog 3 (Drosophila) | 0.012 | ||
RGS16 | regulator of G-protein signaling 16 | 0.012 | ||
MYO1F | myosin IF | 0.012 | ||
SFN | stratifin | 0.012 | ||
MAP2 | microtubule-associated protein 2 | 0.012 | ||
NFAM1 | NFAT activating protein with ITAM motif 1 | 0.012 | ||
PTPN9 | protein tyrosine phosphatase, non-receptor type 9 | 0.012 | ||
CCR2 | chemokine (C-C motif) receptor 2 | 0.012 | ||
DUSP2 | dual specificity phosphatase 2 | 0.012 | ||
DAG1 | dystroglycan 1 (dystrophin-associated glycoprotein 1) | 0.012 | ||
GPR132 | G protein-coupled receptor 132 | 0.012 | ||
PPARG | peroxisome proliferator-activated receptor gamma | 0.012 | ||
ERN1 | endoplasmic reticulum to nucleus signaling 1 | 0.012 | ||
SELPLG | selectin P ligand | 0.012 | ||
APOBR | apolipoprotein B receptor | 0.012 | ||
TBX21 | T-box 21 | 0.012 | ||
TNFRSF4 | tumor necrosis factor receptor superfamily, member 4 | 0.012 | ||
VHL | von Hippel-Lindau tumor suppressor | 0.012 | ||
PLA2G2D | phospholipase A2, group IID | 0.011 | ||
C2 | complement component 2 | 0.011 | ||
NLRP3 | NLR family, pyrin domain containing 3 | 0.011 | ||
VEGFC | vascular endothelial growth factor C | 0.011 | ||
TBX5 | T-box 5 | 0.011 | ||
SOS2 | son of sevenless homolog 2 (Drosophila) | 0.011 | ||
CD40 | CD40 molecule, TNF receptor superfamily member 5 | 0.011 | ||
TRIP10 | thyroid hormone receptor interactor 10 | 0.011 | ||
SLAMF8 | SLAM family member 8 | 0.011 | ||
CELA3B | chymotrypsin-like elastase family, member 3B | 0.011 | ||
BTLA | B and T lymphocyte associated | 0.011 | ||
GGA3 | golgi-associated, gamma adaptin ear containing, ARF binding protein 3 | 0.011 | ||
ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.011 | ||
CD80 | CD80 molecule | 0.011 | ||
FPR3 | formyl peptide receptor 3 | 0.011 | ||
TSHB | thyroid stimulating hormone, beta | 0.011 | ||
KLRK1 | killer cell lectin-like receptor subfamily K, member 1 | 0.011 | ||
EREG | epiregulin | 0.011 | ||
GPR109B | G protein-coupled receptor 109B | 0.011 | ||
COMMD1 | copper metabolism (Murr1) domain containing 1 | 0.011 | ||
CASP8AP2 | caspase 8 associated protein 2 | 0.011 | ||
HTR1B | 5-hydroxytryptamine (serotonin) receptor 1B | 0.011 | ||
SIT1 | signaling threshold regulating transmembrane adaptor 1 | 0.011 | ||
FCGR2A | Fc fragment of IgG, low affinity IIa, receptor (CD32) | 0.011 | ||
HEMGN | hemogen | 0.011 | ||
GZMH | granzyme H (cathepsin G-like 2, protein h-CCPX) | 0.011 | ||
PITPNM1 | phosphatidylinositol transfer protein, membrane-associated 1 | 0.011 | ||
ICOSLG | inducible T-cell co-stimulator ligand | 0.011 | ||
CD300LF | CD300 molecule-like family member f | 0.011 | Human | |
TNS3 | tensin 3 | 0.011 | ||
HDAC2 | histone deacetylase 2 | 0.011 | ||
IL15RA | interleukin 15 receptor, alpha | 0.011 | ||
SIGLEC7 | sialic acid binding Ig-like lectin 7 | 0.011 | ||
GCG | glucagon | 0.011 | ||
IFNA2 | interferon, alpha 2 | 0.011 | ||
NOS2 | nitric oxide synthase 2, inducible | 0.011 | ||
DLL1 | delta-like 1 (Drosophila) | 0.011 | ||
NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.011 | ||
TNFSF15 | tumor necrosis factor (ligand) superfamily, member 15 | 0.010 | ||
OLR1 | oxidized low density lipoprotein (lectin-like) receptor 1 | 0.010 | ||
LRRC32 | leucine rich repeat containing 32 | 0.010 | ||
XCL1 | chemokine (C motif) ligand 1 | 0.010 | Human | |
IFNA16 | interferon, alpha 16 | 0.010 | Human | |
ZNF331 | zinc finger protein 331 | 0.010 | ||
TNFAIP2 | tumor necrosis factor, alpha-induced protein 2 | 0.010 | ||
FOXN1 | forkhead box N1 | 0.010 | ||
CASP3 | caspase 3, apoptosis-related cysteine peptidase | 0.010 | ||
IL17A | interleukin 17A | 0.010 | ||
GEM | GTP binding protein overexpressed in skeletal muscle | 0.010 | ||
PRKCD | protein kinase C, delta | 0.010 | ||
GPSM3 | G-protein signaling modulator 3 | 0.010 | ||
PIK3CB | phosphoinositide-3-kinase, catalytic, beta polypeptide | 0.010 | ||
CNTF | ciliary neurotrophic factor | 0.010 | ||
ROS1 | c-ros oncogene 1 , receptor tyrosine kinase | 0.010 |